Susumu Hirota

Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

Tadashi Kato, Toshi A. Furukawa, Akio Mantani et al. · BMC Medicine · 2018 · 60 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration

Wei Yao, Chao Dong, Cun Zhuang et al. · Pharmacology Biochemistry and Behavior · 2015 · 50 citations

Life Sciences, Immunology, Neuroscience +11

Predicting relapse in major depression after successful initial pharmacological treatment

Tatsuo Akechi, Akio Mantani, Kenichi Kurata et al. · Journal of Affective Disorders · 2019 · 20 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study

Motohiro Ozone, Susumu Hirota, Yu Ariyoshi et al. · Advances in Therapy · 2024 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17